Prostate Cancer News: Below you will find news articles in chronological order (latest at the top). You will find interesting news, events, stories, latest testing and research, activities and much more.
Professor Bart Cornelissen and Dr Tiffany Chan, from the University of Oxford, have received an additional £408,338 award from the charity Prostate Cancer Research (PCR) to continue their innovative work to help a new type of radiotherapy, designed to hunt out cancer even after it has spread, to benefit even more men with prostate cancer. Prostate cancer is now the most commonly diagnosed cancer in the UK and their work could lead to more personalised treatment for those with prostate cancer.More info here
Source: Prostate Cancer Research
Unlike other primary cancers, there is no National Screening Programme for Prostate Cancer. In recent years, the Somerset Cancer Support Association (SPSA) has funded several free PSA testing sessions throughout the county. This work has been coordinated with other support groups countrywide by the Graham Fulford Charitable Trust (GFCT).
Data collected by GFCT now covers more than 154,033 results from over 103,000, men in more than 77,000 different postcodes in the UK.
To support the case for a National Screening Programme data is being collected for analysis by researchers at Manchester University. This two-year project will produce a peer-reviewed paper for publication in leading medical journals.
In Somerset, the SPSA is appealing to all men that have taken the PSA test and received an "abnormal" letter (Red / Amber or top quartile Green) between 2010 and 2020, to take part in a simple online survey. https://mypsatests.org.uk/Research/
Contributions throughout the UK will help form a national picture. The evidence acquired by this research will help persuade the National Screening Council of the need for a PSA screening program for all men in the UK.
If you have had a spacer used to protect your rectum during radiotherapy, your experiences could help NICE decide if the procedure should be used more widely in the NHS.
The National Institute for Health and Care Excellence (NICE) is carrying out a project on the procedure ‘Biodegradable spacer insertion to protect the rectum during radiotherapy for prostate cancer.’ They are looking at how well the procedure is working and if it is safe enough to be used more widely in the NHS in the future.
Radiotherapy to treat prostate cancer can damage the rectum (the end part of the bowel) causing bleeding and leakage of faeces (poo). The aim of this procedure is to reduce the amount of radiation reaching the rectum during radiotherapy, which may reduce the damage. It is usually done using general anaesthetic about 1 week before radiotherapy starts. The rectum is pushed slightly away from the prostate by inserting gel or a balloon (spacer) between them. This remains in place during radiotherapy. It is biodegradable, which means it breaks down and is absorbed by the body after about 6 months.
If this is a procedure that you have had, NICE would like to invite you to provide feedback on your experience of it by completing a survey, which should take no more than 10 minutes to complete. If this is a procedure that you have not had, please do not complete this survey.
If you would like to find out more about NICE or the programme please visit their website.
Source: NICE / Prostate Cancer Research